First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) shot up 0.6% during trading on Monday . The company traded as high as $270.82 and last traded at $269.73. Approximately 26,492 shares were traded during mid-day trading, a decline of 76% from the average session volume of 110,409 shares. The stock had previously closed at $268.15.
First Trust NYSE Arca Biotechnology Index Fund Stock Down 1.7%
The stock has a 50 day moving average of $260.01 and a 200 day moving average of $231.14. The firm has a market cap of $2.93 billion, a price-to-earnings ratio of 21.72 and a beta of 0.67.
Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund
Several hedge funds and other institutional investors have recently made changes to their positions in the company. AG Campbell Advisory LLC bought a new position in First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter valued at approximately $31,000. Cassaday & Co Wealth Management LLC bought a new stake in First Trust NYSE Arca Biotechnology Index Fund during the first quarter worth $34,000. Continuum Advisory LLC bought a new stake in First Trust NYSE Arca Biotechnology Index Fund during the second quarter worth $35,000. Parallel Advisors LLC boosted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 1,300.0% in the 1st quarter. Parallel Advisors LLC now owns 182 shares of the company’s stock valued at $37,000 after purchasing an additional 169 shares in the last quarter. Finally, RMG Wealth Management LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the 1st quarter valued at $54,000.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Further Reading
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
